Climate Change Data

Immutep Limited

Climate Impact & Sustainability Data (2023, 2024)

Reporting Period: 2023

Environmental Metrics

Total Carbon Emissions:Not disclosed
Scope 1 Emissions:Not disclosed
Scope 2 Emissions:Not disclosed
Scope 3 Emissions:Not disclosed
Renewable Energy Share:Not disclosed
Total Energy Consumption:Not disclosed
Water Consumption:Not disclosed
Waste Generated:Not disclosed
Carbon Intensity:Not disclosed

ESG Focus Areas

  • Environmental
  • Social
  • Governance

Environmental Achievements

  • Clinigen Clinical Supplies Management (CCSM) reduced CO2e emitted during FY2021 by 254.6 tonnes compared to 681 tonnes in the prior year. This was partly due to increased home working during COVID-19.
  • WuXi Biologics, Immutep's manufacturer, was certified to ISO 14001 standard in 2022 and received a Two-Star Green Factory recognition.

Social Achievements

  • 68% of Immutep's employees were female as of June 30, 2023.
  • 50% of Immutep's senior executives were female as of June 30, 2023.
  • Immutep fosters a flexible work environment.

Governance Achievements

  • Immutep maintains high standards of integrity and compliance with applicable laws and regulations.
  • Immutep's Board has implemented corporate governance practices aligned with its size and operations, adhering to ASX Corporate Governance Principles and Recommendations.
  • Immutep is dually listed on ASX and NASDAQ markets and is regulated by ASIC and the SEC.

Climate Goals & Targets

Long-term Goals:
  • Not disclosed
Medium-term Goals:
  • Not disclosed
Short-term Goals:
  • Not disclosed

Environmental Challenges

  • Currently, Immutep has not yet begun reporting on its carbon emissions.
Mitigation Strategies
  • Immutep recognizes the significance of adopting best practices and guidelines for climate-related disclosure and will consider conducting a GHG assessment in the future depending on its materiality to the business.

Supply Chain Management

Supplier Audits: Not disclosed

Responsible Procurement
  • Sustainability is one of the selection criteria for Immutep when selecting new vendors. Key vendors comply with high regulatory standards and apply reliable EMS developed according to ISO 14001.

Climate-Related Risks & Opportunities

Physical Risks
  • Not disclosed
Transition Risks
  • Not disclosed
Opportunities
  • Not disclosed

Reporting Standards

Frameworks Used: Null

Certifications: Null

Third-party Assurance: Not disclosed

UN Sustainable Development Goals

  • Not disclosed

Not disclosed

Sustainable Products & Innovation

  • Not disclosed

Awards & Recognition

  • Not disclosed

Reporting Period: 2024

Environmental Metrics

Total Carbon Emissions:Not disclosed
Scope 1 Emissions:Not disclosed
Scope 2 Emissions:Not disclosed
Scope 3 Emissions:Not disclosed
Renewable Energy Share:Not disclosed
Total Energy Consumption:Not disclosed
Water Consumption:Not disclosed
Waste Generated:Not disclosed
Carbon Intensity:Not disclosed

ESG Focus Areas

  • Environmental
  • Social
  • Governance

Environmental Achievements

  • Immutep's offices and laboratory operate at minimal energy and water consumption. Vendors comply with high regulatory standards regarding energy consumption, water usage and hazardous waste disposal and utilize ISO 14001 certified EMS.
  • Reduced carbon emissions through virtual meetings since 2020.

Social Achievements

  • Clinical research conducted in accordance with ICH GCP guidelines, with all patients providing informed consent.
  • Commitment to providing a safe and healthy working environment, including flexible work arrangements.
  • 68% of employees were female as of June 30, 2024; 50% of senior executives were female.

Governance Achievements

  • Commitment to maintaining high standards of integrity and compliance with applicable laws and regulations, including anti-bribery and corruption laws.
  • Adherence to relevant data privacy protections in all operating geographies.
  • Corporate governance practices aligned with company size and complexity, adhering to ASX Corporate Governance Principles and Recommendations.

Climate Goals & Targets

Long-term Goals:
  • Not disclosed
Medium-term Goals:
  • Not disclosed
Short-term Goals:
  • Not disclosed

Environmental Challenges

  • Currently, Immutep has not yet begun reporting on its carbon emissions.
  • Materiality of water usage is considered immaterial at this time.
Mitigation Strategies
  • Will consider conducting a Greenhouse Gas (GHG) assessment in the future depending on its materiality to the business.
  • Water conservation notices erected in offices to remind employees of water conservation tips.

Supply Chain Management

Supplier Audits: Not disclosed

Responsible Procurement
  • Sustainability is one of the selection criteria for Immutep vendors.

Climate-Related Risks & Opportunities

Physical Risks
  • Not disclosed
Transition Risks
  • Not disclosed
Opportunities
  • Not disclosed

Reporting Standards

Frameworks Used: Null

Certifications: Null

Third-party Assurance: Not disclosed

UN Sustainable Development Goals

  • Not disclosed

Not disclosed

Sustainable Products & Innovation

  • Not disclosed

Awards & Recognition

  • Not disclosed